regulates heme oxygenase gene expression and nuclear Nrf2 activation as a mechanism of protection against arsenic exposure in HepG2 cells.
Comparison of the effect of alpha-lipoic acid
and alphatocopherol supplementation on measures of oxidative stress.
Burning mouth syndrome: open trial of psychotherapy alone, medication with alpha-lipoic acid
(thioctic acid), and combination therapy.
In humans, alpha-lipoic acid
has been shown to help lower blood pressure, blood sugar, and triglycerides; reverse insulin resistance; and prevent diabetic neuropathy.
Plasma kinetics, metabolism, and urinary excretion of alpha-lipoic acid
following oral administration in healthy volunteers.
Studies show that topical application of alpha-lipoic acid
provides antioxidant and anti-inflammatory protection that can improve the appearance of aging skin damaged by exposure to the sun.
Effects of treatment with the antioxidant alpha-lipoic acid
on cardiac autonomic neuropathy in NIDDM patients.
Specifically, alpha-lipoic acid
, vitamin C and trivalent chromium (as in the form chromium picolinate) are thought to be preventative.
I have found considerable relief taking a supplement called alpha-lipoic acid
250 mg per day.
SAN FRANCISCO -- Headline and sub-head of release should read: Controlled-Release Alpha-Lipoic Acid
Introduced for Diabetics; The First and Only Proprietary, Controlled-Release Formulation of Alpha-Lipoic Acid
Reduces Oxidative Stress Associated with Diabetes by Antagonizing Excessive Free Radicals at the Cellular Level (sted First-Ever Controlled-Release Alpha-Lipoic Acid
Helps Relieve Diabetic Complications; Medical Research Institute Introduces Glucotize: First and Only Controlled-Release Formulation of Alpha-Lipoic Acid
; Shown to Help Reduce Oxidative Stress Associated with Diabetes at Cellular Level).
An article published in Cell Reports reveals a protective effect for supplementation with alpha-lipoic acid
on telomere length and vascular health in mice given a high-fat diet.
3 g per day of eicosapentaenoic acid (EPA), 300 mg per day of alpha-lipoic acid
(ALA), both treatments, or placebo for 10 weeks.